NCT02164110 - To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children | Biotech Hunter

Enrollment

3,632

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Prevention Harmful Effects

Interventions

BIOLOGICAL

Euvichol

"* Number of doses and intervals: two doses/Weeks 0 and 2~* Method of administration: oral administration~* Dose of drug to be administered: 1.5 mL/dose"

BIOLOGICAL

Shanchol

"* Number of doses and intervals: two doses/Weeks 0 and 2~* Method of administration: oral administration~* Dose of drug to be administered: 1.5 mL/dose"

Trial Locations (1)

4332

Antonio D. Ligsay, MD, Quezon City